(Reuters) - Safe-haven demand due to geopolitical uncertainties and concerns over global economic growth amid U.S. President ...

Since Musk acquired the company, formerly known as Twitter, in October 2022, X's monthly U.S. ad revenue has seen a ...

(Reuters) -Northvolt's co-founder Paolo Cerruti will step down from his role as chief executive officer of its North American ...

Apple (NASDAQ: AAPL) shares were choppy, last down 0.3%, after it reported a slight beat on quarterly figures compared to the ...

NEW YORK (Reuters) -The U.S. dollar edged higher against some of its peers including the yen and euro on Thursday as markets ...

The footwear company posted adjusted earnings per share of $3.00 for the third quarter of fiscal year 2025, surpassing ...

It's been a mixed bag for the 'Magnificent 7' this week. Nvidia (NASDAQ: NVDA) shares got hammered on Monday by the DeepSeek ...

The quantum computing sector has been on fire in recent months, fueled by a game-changing breakthrough from tech titan Google ...

ECB President Christine Lagarde made it clear that Bitcoin would not be considered for the eurozone's central bank reserves.

Cryptocurrency exchange Kraken announced the reintroduction of its staking services for U.S. clients, featuring 17 digital ...

Despite the earnings beat, Intel's guidance for the first quarter of 2025 fell short of expectations. The company forecasts revenue between $11.7 billion and $12.7 billion, below the analyst consensus ...

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...